Brivudine (Brivox; Helpin ;Zerpex; BVDU; RP101; bromovinyl-deoxyuridine) is a novel and potent uridine analogue and nucleoside analogue with pro-apoptotic and chemosensitizing activities.

Valganciclovir HCl is the L-valyl ester prodrug of ganciclovir which is an antiviral drug used to treat cytomegalovirus infections.

Ganciclovir (2′-Nor-2′-deoxyguanosine, BW-759) is a novel and potent herpes simplex virus (HSV) inhibitor.

Ganciclovir sodium, an acyclovir analog, is a novel and potent antiviral drug used to treat or prevent cytomegalovirus (CMV) infections.

Maribavir (1263W94; BW-1263W94; GW-1263; SHP-620; GW-257406X; VP-41263; Livtencity), an experimental oral antiviral (anti-CMV) drug candidate, is a novel and potent inhibitor of histone phosphorylation catalyzed by wild-type pUL97 in vitro with an IC50 of 3 nM.

Letermovir (formerly MK-8828; MK8828; AIC-246; AIC246; trade name: Prevymis) is a potent anti-cytomegalovirus (CMV) / antiviral drug approved on 11/8/2017 by FDA to prevent infection after bone marrow transplant.

Tomeglovir (also known as BAY-38-4766) is a novel, potent and non-nucleoside anti-CMV (cytomegalovirus) agent which inhibits processing of viral DNA-concatemers with IC50s of 0.34 μM and 0.039 μM for HCMV and MCMV.